Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Durandy

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|August 27, 1983
Bone-marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis, and oxidative response during opsonised particle phagocytosisA Fischer, P H Trung, B Descamps-Latscha, et al.
The Pediatric Infectious Disease Journal|June 1, 1994
Severe acute paracoccidioidomycosis in childrenG Benard, N M Orii, H H Marques, et al.
European Journal of Cancer|April 1, 1977
An effect human leukaemic cell line: RehC Rosenfeld, A Goutner, A M Venuat, et al.
Blood|October 27, 1998
Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcomeM Benkerrou, J P Jais, V Leblond, et al.
Methods (San Diego, Calif.)|January 1, 1997
Production and roles of IL-6, IL-10, and IL-13 in B-lymphocyte malignancies and in B-lymphocyte hyperactivity of HIV infection and autoimmunityD Emilie, W Zou, R Fior, et al.
The Journal of Biological Chemistry|March 31, 1995
Recombinant soluble trimeric CD40 ligand is biologically activeG J Mazzei, M D Edgerton, C Losberger, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1995
Responses of T and B lymphocytes to a Paracoccidioides brasiliensis cell wall extract in healthy sensitized and nonsensitized subjectsG Benard, A Durandy, C M Assis, et al.
Clinical Immunology (Orlando, Fla.)|December 9, 2000
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndromeY Minegishi, A Lavoie, C Cunningham-Rundles, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expressionA Durandy, C Hivroz, F Mazerolles, et al.
Blood|March 10, 2001
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trialE Haddad, S Paczesny, V Leblond, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|August 27, 1983
Bone-marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis, and oxidative response during opsonised particle phagocytosisA Fischer, P H Trung, B Descamps-Latscha, et al.
The Pediatric Infectious Disease Journal|June 1, 1994
Severe acute paracoccidioidomycosis in childrenG Benard, N M Orii, H H Marques, et al.
European Journal of Cancer|April 1, 1977
An effect human leukaemic cell line: RehC Rosenfeld, A Goutner, A M Venuat, et al.
Blood|October 27, 1998
Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcomeM Benkerrou, J P Jais, V Leblond, et al.
Methods (San Diego, Calif.)|January 1, 1997
Production and roles of IL-6, IL-10, and IL-13 in B-lymphocyte malignancies and in B-lymphocyte hyperactivity of HIV infection and autoimmunityD Emilie, W Zou, R Fior, et al.
The Journal of Biological Chemistry|March 31, 1995
Recombinant soluble trimeric CD40 ligand is biologically activeG J Mazzei, M D Edgerton, C Losberger, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1995
Responses of T and B lymphocytes to a Paracoccidioides brasiliensis cell wall extract in healthy sensitized and nonsensitized subjectsG Benard, A Durandy, C M Assis, et al.
Clinical Immunology (Orlando, Fla.)|December 9, 2000
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndromeY Minegishi, A Lavoie, C Cunningham-Rundles, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1997
Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expressionA Durandy, C Hivroz, F Mazerolles, et al.
Blood|March 10, 2001
Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trialE Haddad, S Paczesny, V Leblond, et al.
Pageof 13